NewsBenzinga吉利德科学同意以12.75亿美元交易收购PepStar Therapeutics的口服IL-23R抑制剂项目 吉利德科学同意以12.75亿美元交易收购PepStar Therapeutics的口服IL-23R抑制剂项目 Benzinga 2026.10.22 20:07 (GMT+0) Open on Benzinga Other news Hyperliquid’s Yan and CME’s Duffy Split Over Who Must Bear US Compliance Here are the top AI agents that can live in your text messages Applied Materials: It's Time To Double Down (Earnings Preview) (NASDAQ:AMAT) Kinder Morgan (KMI) Expands Backlog Driven By Major Natural Gas Projects TeraWulf Raises Revolving Credit Facility by 60% to About $400 Million Tesla Stock: 2027 Could Be A Massive Growth Inflection Point (NASDAQ:TSLA)
